- Blueprint Medicines ( BPMC ) -13% on reports to seek label expansion for systemic mastocytosis therapy after trial win .
- Artelo Biosciences ( ARTL ) -13% .
- Krispy Kreme ( DNUT ) -12% on Q2 earnings release .
- Forza X1 ( FRZA ) -12% .
- PAVmed ( PAVM ) -11% on Q2 earnings release .
- Kidpik ( PIK ) -11% on Q2 earnings release .
- Unity Biotechnology ( UBX ) -9% on $25M common stock offering .
- Stronghold Digital Mining ( SDIG ) -9% on Q2 earnings release .
- GigaMedia ( GIGM ) -9% .
- F45 Training Holdings ( FXLV ) -9% .
- Sibanye Stillwater ( SBSW ) -8% .
- GreenBox ( GBOX ) -6% on announcing restructuring of convertible note terms .
- Zymergen ( ZY ) -6% .
- WeTrade Group ( WETG ) -6% .
- Option Care Health ( OPCH ) -6% after pricing secondary share offering by WBA .
- IZEA Worldwide ( IZEA ) -6% .
- Sanofi ( SNY ) -6% as breast cancer drug amcenestrant development stopped after another trial failure .
- Team ( TISI ) -5% .
- Senmiao Technology ( AIHS ) -5% .
For further details see:
Sanofi, Sibanye Stillwater, Option Care Health among premarket losers' pack